Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.
about
Biochemical Characterization and Validation of a Catalytic Site of a Highly Thermostable Ts2631 Endolysin from the Thermus scotoductus Phage vB_Tsc2631Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosaBacteriophages and Their Immunological Applications against Infectious Threats.Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii.'Artilysation' of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci.Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells.Antimicrobial Activity and Phytochemical Analysis of Organic Extracts from Cleome spinosa Jaqc.Antimicrobial Peptides: An Emerging Category of Therapeutic Agents.Development of Phage Lysin LysA2 for Use in Improved Purity Assays for Live Biotherapeutic Products.The Vibrio parahaemolyticus-infecting bacteriophage qdvp001: genome sequence and endolysin with a modular structure.Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.Recent advances in therapeutic delivery systems of bacteriophage and bacteriophage-encoded endolysins.The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly.Dual Active Site in the Endolytic Transglycosylase gp144 of Bacteriophage phiKZ.The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus.DUF3380 Domain from a Salmonella Phage Endolysin Shows Potent N-Acetylmuramidase ActivityAntimicrobial resistance in the 21st century.Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.Himatanthus drasticus Leaves: Chemical Characterization and Evaluation of Their Antimicrobial, Antibiofilm, Antiproliferative Activities.Lysozyme activity of the Ruminococcus champanellensis cellulosome.Deciphering how Cpl-7 cell wall-binding repeats recognize the bacterial peptidoglycan.Dissecting the structure-function relationship in lysozyme domain of mycobacteriophage D29-encoded peptidoglycan hydrolase.Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation.Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials.Potential for Bacteriophage Endolysins to Supplement or Replace Antibiotics in Food Production and Clinical Care.
P2860
Q28548052-D2485D3E-9FAE-42AE-8BC5-09CB0016BD57Q28603769-4A064BFC-1150-4290-AE4C-F773B111C9AEQ30234522-5EFF0ECD-403E-4EB3-86E7-4B19F1B04007Q30761262-DED8AF24-18AC-4D3A-968F-134CE10FDFAFQ30825736-F01CF326-F006-4282-BB51-0DF1D3054BF9Q35808662-6A1B80EF-E18B-447A-9A93-C0FC0C1D582FQ37045977-ABC1449F-531F-4E85-80EB-17D9D5F00BA7Q37532896-680FE780-5518-4361-9672-D044E74A1680Q38676308-D1066F06-6FAD-495D-BF80-98884BAA7025Q38845481-6B13F5F7-58DC-4584-A7BE-1BE2AC8F2274Q39029801-442ACA53-D52E-4BCE-B366-5C960F787AAEQ39386520-8332B2FE-5B44-43A8-87EE-8927F34FFD24Q40125437-CE2ADED9-CDAC-4F97-9FF0-BAE51E5F66E1Q40230447-40587309-9DF2-4F8F-B7FB-6FD96072643DQ40363693-5A82BCA6-380A-48EC-AC5E-4E70C8C5F73CQ40413579-7106B48A-F157-4A32-87D4-AA79D3988E11Q41894598-39C1D718-147E-469F-AE02-9807E756124AQ43768686-DFEA89B8-F565-4D97-B08B-B8F66CE0FCB1Q46251747-668DE9BC-77AA-43FC-B9BA-E2270A0E61B5Q46358598-58FB7186-7E67-42CE-BD70-BB46BEF0033CQ46497790-D09E538D-68BC-47B5-8E62-41558FEF8A08Q47305260-5E3AB6EA-9B9C-42CC-B2C2-E7A92A25A93DQ47645868-C1CA4044-7155-4280-AB00-02A5572D7563Q52315864-56062D79-1161-43EF-8E74-87F82F1E1D86Q52642775-CBCD6143-65A4-4B78-9D33-4CBE1CE5EA8DQ52679093-8F11E228-765B-4CAD-8DA5-B8262E618E69
P2860
Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Breaking barriers: expansion o ...... gainst Gram-negative bacteria.
@en
type
label
Breaking barriers: expansion o ...... gainst Gram-negative bacteria.
@en
prefLabel
Breaking barriers: expansion o ...... gainst Gram-negative bacteria.
@en
P2860
P356
P1433
P1476
Breaking barriers: expansion o ...... gainst Gram-negative bacteria.
@en
P2093
Yves Briers
P2860
P304
P356
10.2217/FMB.15.8
P50
P577
2015-01-01T00:00:00Z